Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists (news.ycombinator.com)
2.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s (news.ycombinator.com)
3.
Additional Benefits For Brain, Heart, and Lungs Found for Drugs Like Viagra and Cialis (slashdot.org)
4.
This smartwatch says it can evaluate your diabetes risk without a fingerprick (androidauthority.com)
5.
The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs (feeds.nature.com)
6.
A Continuous Glucose Monitor Might Help You Lose Weight (2026) (wired.com)
7.
A foundation model for continuous glucose monitoring data (feeds.nature.com)
8.
Heart and Kidney Diseases and Type 2 Diabetes May Be One Ailment (news.ycombinator.com)
9.
Bad Air Is One of the Biggest Threats to Your Health. Here’s How to Protect Yourself (wired.com)
10.
A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk (cnet.com)
11.
Costco Is Now Selling Ozempic and Other GLP-1 Drugs. These Are the Benefits and Risks You Need to Know (cnet.com)
12.
Ozempic and Other GLP-1s: Know the Benefits, Risk Factors and Overdose Info (cnet.com)
13.
Cannabis use associated with quadrupled risk of developing type 2 diabetes (news.ycombinator.com)
14.
Gene-edited pancreatic cells transplanted into a patient with type 1 diabetes (news.ycombinator.com)
15.
CRISPR offers new hope for treating diabetes (news.ycombinator.com)
16.
CRISPR Offers New Hope for Treating Diabetes (news.ycombinator.com)
17.
Crispr Offers New Hope for Treating Diabetes (wired.com)
18.
Ozempic Might Be a Dementia Buster, Too (gizmodo.com)
Today's top topics: anthropic apple openai meta google
View all today's topics →